Risk groups for non-melanoma skin cancer

Last medical review:

Doctors classify most non-melanoma skin cancers into risk groups that are based on several prognostic factors, including the size of the cancer and where it’s located.

The risk groups allow the doctor to estimate the chance that the cancer will come back (recur). Doctors also use the risk groups to help plan the best treatment.

Basal cell carcinoma (BCC)

The prognosis is usually very good for BCC because it can be found and treated early. BCC is classified as low or high risk based on its risk of coming back. If the BCC has any high-risk factor, it is automatically classified as high-risk BCC.

Low-risk BCC

BCC is put in the low-risk group when any of the following are true:

  • It is smaller than 2 cm and on the central part of the body (called the trunk), upper arms or legs.
  • It is smaller than 1 cm on the cheeks, forehead, scalp or neck.
  • It is nodular or superficial.
  • It is a primary cancer that has not come back after treatment.
  • The edge of the cancerous area is clear and smooth.
  • The immune system is not weakened.
  • There was no previous radiation therapy to the area.
  • There is no cancer in or around nerves.

High-risk BCC

BCC is put in the high-risk group when any of the following are true:

  • It is larger than 2 cm and on the trunk of the body, arms or upper legs.
  • It is larger than 1 cm on the cheeks, forehead, scalp or neck.
  • It is any size and on the eyelids, eyebrows, temples, nose, lips, ears, genitals, hands or feet.
  • It is an aggressive (fast-growing and fast-spreading) subtype, such as infiltrative, morpheaform or micronodular.
  • It has come back after treatment.
  • The edge of the cancerous area is uneven.
  • The immune system is weakened.
  • There was previous radiation therapy to the area.
  • The cancer has grown into or around nerves.

Squamous cell carcinoma (SCC)

SCC is classified as low or high risk based on its risk of coming back. If the SCC has any high-risk factor, it’s automatically classified as high-risk SCC.

Low-risk SCC

SCC is put in the low-risk group when any of the following are true:

  • It is smaller than 2 cm and on the central part of the body (called the trunk), upper arms or legs.
  • It is smaller than 1 cm on the cheeks, forehead, scalp or neck.
  • It is less than 2 mm deep.
  • The edge of the cancerous area is clear and smooth.
  • It is low grade.
  • It is growing slowly.
  • It is caused by ultraviolet radiation.
  • It is a primary cancer that has not come back after treatment.
  • The immune system is not weakened.
  • There was no previous radiation therapy to the area.
  • There is no cancer in or around nerves.

High-risk SCC

SCC is put in the high-risk group when any of the following are true:

  • It is larger than 2 cm and is on the trunk of the body, arms or upper legs.
  • It is larger than 1 cm and is on the cheeks, forehead, scalp, nails or ankles.
  • It is any size and on the head, neck, eyelids, eyebrows, temples, nose, lips, ears, genitals, hands, feet or skin around the eyes.
  • It is 2 mm or more deep.
  • It is high grade.
  • It is growing quickly.
  • The edge of the cancerous area is uneven.
  • It is a high-risk subtype, such as desmoplastic SCC or adenosquamous carcinoma of the skin.
  • It has come back after treatment.
  • The immune system is weakened.
  • There was previous radiation therapy to the area.
  • It started from a chronic wound or scar.
  • The cancer has grown into or around nerves, the lymphatic system or blood system.

Expert review and references

  • Guideline Resource Unit (GURU). Mohs Micrographic Surgery. Edmonton: Alberta Health Services; 2019: Clinical Practice Guideline CU-017 Version: 1. https://www.albertahealthservices.ca/info/cancerguidelines.aspx.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Basal Cell Skin Cancer Version 2.2024. 2023.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Squamous Cell Skin Cancer Version 1.2024. 2023.
  • Sapijaszko M, Zloty D, Bourcier M, Poulin Y, Janiszewski P, Ashkenas J. Non-melanoma skin cancer in Canada chapter 5: management of squamous cell carcinoma. Journal of Cutaneous Medicine and Surgery. 2015.
  • Yu SH, Rasar Young M, Leffell DJ, Christensen SR. Cancer of the skin. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, [chapter 62], https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.
  • Zloty D, Guenther LC, Sapijaszko M et al. Non-melanoma skin cancer in Canada chapter 4: management of basal cell carcinoma. Journal of Cutaneous Medicine and Surgery. 2015.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society